Lyra Therapeutics (LYRA) SEC Filings & 10K Form $11.34 -0.51 (-4.30%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$11.15 -0.19 (-1.67%) As of 06/13/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Lyra Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView06/09/20256:00 AMLyra Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/02/20256:22 AMLyra Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/25/20252:41 PMLyra Therapeutics (Subject)Waksal Harlan (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 04/09/20252:44 PMLyra Therapeutics (Subject)Palasis Maria (Reporting)Form 144Notice of proposed sale of securities pursuant to Rule 144 04/04/20257:59 AMLyra Therapeutics (Filer)Form DEF 14A04/04/20258:01 AMLyra Therapeutics (Filer)Form DEFA14A03/25/20253:30 PMLyra Therapeutics (Filer)Form PRE 14A02/14/20255:22 PMCITADEL ADVISORS LLC (Filed by)Lyra Therapeutics (Subject)Form SCHEDULE 13G/A12/16/20248:02 PMLyra Therapeutics (Subject)PERCEPTIVE ADVISORS LLC (Filed by)Form SC 13D/A12/13/20244:06 PMLyra Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/11/20245:39 PMLyra Therapeutics (Issuer)Waksal Harlan (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/11/20245:54 PMLyra Therapeutics (Issuer)Palasis Maria (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/14/20246:48 PMLyra Therapeutics (Subject)Point72 Asset Management, L.P. (Filed by)Form SC 13G/A11/14/20244:48 PMLyra Therapeutics (Subject)Samsara BioCapital, L.P. (Filed by)Form SC 13G/A11/14/20244:49 PMLyra Therapeutics (Subject)Venrock Healthcare Capital Partners II, L.P. (Filed by)Form SC 13G/A11/14/20243:53 PMLyra Therapeutics (Subject)Nantahala Capital Management, LLC (Filed by)Form SCHEDULE 13G/A08/15/20245:31 PMLyra Therapeutics (Subject)PERCEPTIVE ADVISORS LLC (Filed by)Form SC 13D/A07/23/20243:05 PMLyra Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Monogram Orthopaedics 10K Form Microbot Medical 10K Form FONAR 10K Form Nutriband 10K Form Sensus Healthcare 10K Form Inovio Pharmaceuticals 10K Form TELA Bio 10K Form InspireMD 10K Form Milestone Scientific 10K Form Vivani Medical 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:LYRA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LYRA Stock Free LYRA Stock Alerts